Microbiota-Based Live Biotherapeutic Products for Clostridioides Difficile Infection- The Devil is in the Details by Monday L, Tillotson G, Chopra T

Get full text

ANTIBIOTIC-PROPHYLAXIS FOR ERCP - A RANDOMIZED CLINICAL-TRIAL OF CIPROFLOXACIN VERSUS CEFUROXIME by Mehal, W, Culshaw, K, Tillotson, G, Chapman, R

Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis. by Mehal, W, Culshaw, K, Tillotson, G, Chapman, R

Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection by Feuerstadt P, Oneto C, Tillotson G, Van Hise NW

Get full text

Clostridium difficile in 7 European countries and North America: Fidaxomicin vs vancomycin therapy by Crook, D, Cornely, O, Esposito, R, Poirier, A, Somero, M, Weiss, K, Tillotson, G